(Bornstein et al., 2020) proposed that COVID-19 infection may reduce the expression of angiotensin-converting enzyme 2 (ACE2), causing cell damage, excessive inflammation, and respiratory failure. The gene discussed is ACE2; the disease is respiratory failure.